Publikationen in Zusammenarbeit mit Forschern von Hospital Clínico San Carlos de Madrid (3)

2019

  1. Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients

    Pathology and Oncology Research, Vol. 25, Núm. 1, pp. 269-278

2017

  1. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept

    PLoS ONE, Vol. 12, Núm. 8

2015

  1. Identification of Poor-outcome Biliopancreatic Carcinoma Patients with Two-marker Signature Based on ATF6α and p-p38 "sTARD Compliant"

    Medicine (United States), Vol. 94, Núm. 45, pp. e1972